US 10202618
Method of treating type I diabetes using an AAV vector encoding uracortin 2
granted A61KA61K31/436A61K31/65
Quick answer
US patent 10202618 (Method of treating type I diabetes using an AAV vector encoding uracortin 2) held by The Regents of the University of California expires Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Feb 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/436, A61K31/65, A61K38/2221, A61K38/2228